Skip to content

Find now all the information you are looking for

  • Services
  • About
    • Quality policy
    • Certifications
    • 15 Anniversary
    • Work with us
  • FAQ
  • Countries
  • Resources
    • News
    • Blog
    • Library
    • Acronyms and definitions
  • Contact
  • +39 0542 643496
  • en
Thema Srl

Category: Switzerland

Posted on 14 December 202114 December 2021

Why is Switzerland considered a Third Country by Europe?

Starting from May 26, 2021, in accordance with the full application of MDR (EU) 2017/745 Regulation on Medical Devices and …

Continue reading “Why is Switzerland considered a Third Country by Europe?”

Posted on 14 December 202114 December 2021

Swiss Exit: what requirements should EU Manufacturers of Medical Devices satisfy now?

As of May 26, 2021, Switzerland has fully-fledged become a Third Country (Swiss Exit) and Swiss Manufacturers are treated as …

Continue reading “Swiss Exit: what requirements should EU Manufacturers of Medical Devices satisfy now?”

Posted on 14 December 202114 December 2021

For which Medical Devices is it necessary to appoint a Swiss Authorised Representative?

The designation of the Swiss Authorised Representative (CH REP) is required to market all Medical Devices, including legacy devices, i.e. …

Continue reading “For which Medical Devices is it necessary to appoint a Swiss Authorised Representative?”

Posted on 14 December 202114 December 2021

Do Swiss Authorised Representative and Importers of Medical Devices have to register in EUDAMED?

Since Switzerland is considered a Third Country by the EU, its registration database is denied. Swiss REP and Importer in …

Continue reading “Do Swiss Authorised Representative and Importers of Medical Devices have to register in EUDAMED?”

Posted on 14 December 202114 December 2021

Who is responsible for the CH REP Swiss Authorised Representative designation?

All Manufacturers located outside Switzerland who intend to start or keep marketing their own Medical Devices in Switzerland must designate …

Continue reading “Who is responsible for the CH REP Swiss Authorised Representative designation?”

Posted on 14 December 202114 December 2021

Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?

According to Medical Devices Ordinance (MedDO) Article 104a, several transitional periods for the nominee of the Swiss Authorised Representative CH …

Continue reading “Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?”

Posted on 14 December 202114 December 2021

Is CE certificate on Medical Devices valid in Switzerland?

Since Switzerland is a Third Country, there is no CE certificate which is valid in Switzerland, that is to say …

Continue reading “Is CE certificate on Medical Devices valid in Switzerland?”

Posted on 14 December 202114 December 2021

Which are the deadlines for UDI affixing?

Deadlines for UDI (Unique Device Identifier) affixing change depending on Medical Devices risk classes. With regards to UDI affixing, Medical …

Continue reading “Which are the deadlines for UDI affixing?”

Posted on 14 December 202114 December 2021

How must the CHE REP symbol be used on the device packaging?

The Regulatory Authority Swissmedic provides accurate information on the usage of the Swiss Representative CH REP symbol which is very …

Continue reading “How must the CHE REP symbol be used on the device packaging?”

Posted on 14 December 202114 December 2021

Is CE marking still valid with Swiss – Exit?

While CE certificate is no longer valid, the CE marking placed on the product is still valid. CE marking though …

Continue reading “Is CE marking still valid with Swiss – Exit?”

Search

Subscribe to our newsletter






Name and Surname
Company
Position
Email
Consent to processing of data
in accordance with D. Lgs. 196/2003 adapted to the GDPR 679/16 EU by the D. Lgs. 101/2018 and receive the periodic NEWSLETTER INFORMATION Thema S.r.l
Information concerning the processing of personal data
 

Services

  • Strategic Regulatory Consulting
  • CE Certification Support
  • Italian and European Ministerial Registrations
  • International Registrations outside the EU
  • Local Representative 
  • Quality and International GMPs

FAQ

+ What is a regulatory strategy

  • How do I select the country where I want to sell my devices?

  • How do I find the information I need to sell my devices?

+ How do I register medical devices in the world

  • What is the 510(k)?

  • Marketing in China: what is the Legal Agent responsible for?

  • Marketing in Brazil: do I need to get the INMETRO mark?

  • Marketing in Canada: what is the difference between MDAL and MDEL?

+ Why is the CE marking required

  • How will the IVDR 2017/746 affect the Quality System Management?

  • What does the entry into force of IVDR 2017/746 entail for manufacturers of in vitro diagnostic medical devices?

  • What are the main changes compared to the previous Directive 98/79/EC?

  • When will the IVDR 2017/746 enter into force?

  • When is the Notified Body’s intervention needed?

  • When do I have to appoint an Authorized Representative?

  • How can I establish a medical device risk class ?

  • What is the OBL contract?

+ What are the GMP requirements

  • GMP FDA: which production processes should I validate?

  • Marketing in Canada: what are the disclosure obligations required by Directive SOR 98-282?

  • How many reviews should I expect during the device design ?

  • cGMp FDA: when can I exclude the design from my quality system according to the US cGMP?

  • What is MDSAP?

+ How to register radiation emitting medical devices with the CDRH

  • What is the Product (Initial) Report to the CDRH?

  • What is the Accession Number?

  • Which medical devices are classified as electronic products that emit radiation?

  • What does the CDRH do?

+ MDR (EU) 2017/745 impact on CE MDD certificates during the “period of grace”?

  • What is the “period of grace” and how can I take advantage of it?

  • What is the difference between market surveillance, post-market surveillance (PMS) and vigilance?

  • What are the MDR requirements for post-market surveillance, market surveillance and vigilance?

  • What is the “post-market surveillance system”?

  • How can I continue to sell my devices after the full implementation of MDR?

+ IVDR (EU) 2017/746

  • What is the in vitro diagnostic medical devices regulation IVDR (EU) 2017/746? When does it apply?

  • When do Manufacturers of in vitro diagnostic medical devices have to conform to the IVDR (EU) 2017/746?

  • How does the Regulation on in Vitro Diagnostic Medical Devices (IVDR) affect the Quality Management System?

  • What are the main changes provided for in the Regulation on in Vitro Diagnostic Medical Devices IVDR (EU) 2017/746?

  • Is it possible to self-certificate devices in the field of the Regulation on in Vitro Diagnostic Medical Devices IVDR (EU) 2017/746?

  • What is the “sell off” provision?

  • Transitional period: can in vitro Diagnostic Medical Devices, conform to the current IVDD, be placed on the EU market after May 26, 2022?

+ Swiss-Exit: requirements to market Medical Devices in Switzerland

    BLOG

    • 14 December 2021
      Why is Switzerland considered a Third Country by Europe?
    • 14 December 2021
      Swiss Exit: what requirements should EU Manufacturers of Medical Devices satisfy now?
    • 14 December 2021
      For which Medical Devices is it necessary to appoint a Swiss Authorised Representative?
    • 14 December 2021
      Do Swiss Authorised Representative and Importers of Medical Devices have to register in EUDAMED?
    • 14 December 2021
      Who is responsible for the CH REP Swiss Authorised Representative designation?
    Blog
    • Linkedin @en
    • YouTube @en
    • Email @en

    Subscribe to the newsletter






    Name and Surname
    Company
    Position
    Email
    Consent to processing of data
    in accordance with D. Lgs. 196/2003 adapted to the GDPR 679/16 EU by the D. Lgs. 101/2018 and receive the periodic NEWSLETTER INFORMATION Thema S.r.l
    Information concerning the processing of personal data
     

    Thema Srl

    Via Saragat, 5
    40026 Imola (BO)
    Italia

    Tel. +39 0542 643496
    Fax +39 0542 641833
    info@thema-med.com

    C.F. / P.IVA 02770361208
    N. REA BO n.466056
    Capitale Sociale € 50.000 i.v.

     

     

     

    logo RAPS Enterprise Member

    Disclaimer | Copyright | Informativa Clienti | Cookie e Privacy Policy | Lavora con noi
    Designed by VITA DA WEB and powered by WordPress
    This site uses some cookies to ensure a better user experience, by recording your preferences and every visit you repeat . By clicking on "I accept" you will give your consent to use ALL cookies.
    Cookie and Privacy Policy settings ACCEPT
    Privacy & Cookies Policy

    Cookie and Privacy Policy Overview

    This website uses cookies to improve your experience while browsing the website. Of these, cookies classified as necessary are stored in your browser as they are essential for the functioning of the basic functionality of the website. We also use third party cookies. parts that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to disable these cookies. But disabling some of these cookies may affect your browsing experience. Read here the extended information of COOKIE POLICY AND PRIVACY POLICY
    Required
    Always Enabled

    Necessary cookies are essential to ensure all website functionality. This category only includes cookies that ensure the basic and security features of the website. These cookies do not store any type of personal information.

    Unrequired

    All cookies that may not be necessary for the functionality of the website and which are used to collect user personal data through Analytics, Google Ads ads and other embedded content. Consent is required for this type of cookie.